# Observational Study on Chronic Myeloid Leukemia Patients in Any Phase Treated With Ponatinib (Iclusig®) at Any Dose

> **NCT03933852** · — · UNKNOWN · sponsor: **University of Jena** · enrollment: 100 (estimated)

## Conditions studied

- Chronic Myeloid Leukemia, Chronic Phase

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03933852
- **Lead sponsor:** University of Jena
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-07-08
- **Primary completion:** 2024-06-30
- **Final completion:** 2024-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2023-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03933852

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03933852, "Observational Study on Chronic Myeloid Leukemia Patients in Any Phase Treated With Ponatinib (Iclusig®) at Any Dose". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT03933852. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*